High-dose tumor necrosis factor-alpha leads to the systemic inflammatory response syndrome

Am J Med. 1998 Oct;105(4):346-7. doi: 10.1016/s0002-9343(98)00265-4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Humans
  • Liver Neoplasms / drug therapy
  • Male
  • Systemic Inflammatory Response Syndrome / chemically induced*
  • Tumor Necrosis Factor-alpha / administration & dosage
  • Tumor Necrosis Factor-alpha / adverse effects*

Substances

  • Tumor Necrosis Factor-alpha